Literature DB >> 30465229

The Inclusion of Spillover Effects in Economic Evaluation: A Public Health Economics Perspective.

Rhiannon Tudor Edwards1.   

Abstract

Mesh：

Year:  2019        PMID： 30465229     DOI： 10.1007/s40273-018-0748-9

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  5 in total

Review 1.  Paradigms and research programmes: is it time to move from health care economics to health economics?

Authors:  R T Edwards
Journal:  Health Econ       Date:  2001-10       Impact factor: 3.046

2.  The cost-effectiveness of public health interventions.

Authors:  Lesley Owen; Antony Morgan; Alastair Fischer; Simon Ellis; Andrew Hoy; Michael P Kelly
Journal:  J Public Health (Oxf)       Date:  2011-09-20       Impact factor: 2.341

3.  The Inclusion of Spillover Effects in Economic Evaluations: Not an Optional Extra.

Authors:  Werner B F Brouwer
Journal:  Pharmacoeconomics       Date:  2019-04       Impact factor: 4.981

4.  Expanding the Scope of Costs and Benefits for Economic Evaluations in Health: Some Words of Caution.

Authors:  Christopher McCabe
Journal:  Pharmacoeconomics       Date:  2019-04       Impact factor: 4.981

5.  Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.

Authors:  Gillian D Sanders; Peter J Neumann; Anirban Basu; Dan W Brock; David Feeny; Murray Krahn; Karen M Kuntz; David O Meltzer; Douglas K Owens; Lisa A Prosser; Joshua A Salomon; Mark J Sculpher; Thomas A Trikalinos; Louise B Russell; Joanna E Siegel; Theodore G Ganiats
Journal:  JAMA       Date:  2016-09-13       Impact factor: 56.272
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.